267 related articles for article (PubMed ID: 28194534)
1. The impact of physician-level drug budgets on prescribing behavior.
Fischer KE; Koch T; Kostev K; Stargardt T
Eur J Health Econ; 2018 Mar; 19(2):213-222. PubMed ID: 28194534
[TBL] [Abstract][Full Text] [Related]
2. [Generic drugs: good or bad? Physician's knowledge of generic drugs and prescribing habits].
García AJ; Martos F; Leiva F; Sánchez de la Cuesta F
Gac Sanit; 2003; 17(2):144-9. PubMed ID: 12729542
[TBL] [Abstract][Full Text] [Related]
3. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
Datta A; Dave D
Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
[TBL] [Abstract][Full Text] [Related]
4. The impact of a general practice group intervention on prescribing costs and patterns.
Walker J; Mathers N
Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
[TBL] [Abstract][Full Text] [Related]
5. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
Jünger C; Rathmann W; Giani G
Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three methods of setting prescribing budgets, using data derived from defined daily dose analyses of historic patterns of use.
Maxwell M; Howie JG; Pryde CJ
Br J Gen Pract; 1998 Aug; 48(433):1467-72. PubMed ID: 10024703
[TBL] [Abstract][Full Text] [Related]
7. Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany.
Schwermann T; Greiner W; v d Schulenburg JM
Value Health; 2003; 6 Suppl 1():S20-30. PubMed ID: 12846923
[TBL] [Abstract][Full Text] [Related]
8. An epidemiologic approach to drug prescribing quality assessment: a study in primary care practice in France.
Coste J; Venot A
Med Care; 1999 Dec; 37(12):1294-307. PubMed ID: 10599610
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
Prosser H; Walley T
Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
[TBL] [Abstract][Full Text] [Related]
10. Prescribing indicators and their use by primary care groups to influence prescribing.
Ashworth M; Golding S; Majeed A
J Clin Pharm Ther; 2002 Jun; 27(3):197-204. PubMed ID: 12081633
[TBL] [Abstract][Full Text] [Related]
11. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
[TBL] [Abstract][Full Text] [Related]
12. Perception and attitude of Korean physicians towards generic drugs.
Ryu M; Kim J
BMC Health Serv Res; 2017 Aug; 17(1):610. PubMed ID: 28851368
[TBL] [Abstract][Full Text] [Related]
13. Cross verification of prescribing trends through loop evaluation of physicians, patients and medical store personnel.
Husnain SZ; Bukhari NI; Hussain K; Babar ZU; Hashmi FK; Saleem Z; Salman M; Curley L
BMC Health Serv Res; 2019 May; 19(1):328. PubMed ID: 31118096
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders.
Wilson RP; Hatcher J; Barton S; Walley T
Br J Gen Pract; 1999 Jun; 49(443):431-5. PubMed ID: 10562740
[TBL] [Abstract][Full Text] [Related]
15. Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines.
Roberts SJ; Bateman DN; Smith JM
Br J Gen Pract; 1997 Jan; 47(414):13-8. PubMed ID: 9115786
[TBL] [Abstract][Full Text] [Related]
16. Prescribing pattern of analgesics in orthopedic in-patient department at tertiary care hospital in Guwahati, Assam, Northeast India.
Choudhury DK; Bezbaruah BK
Indian J Pharmacol; 2016; 48(4):377-381. PubMed ID: 27756947
[TBL] [Abstract][Full Text] [Related]
17. Does increased use of generic medicines by elders in Belgium help to contain escalating health care budgets?
Dylst P; Vulto A; Simoens S
J Aging Soc Policy; 2014; 26(3):266-80. PubMed ID: 24716815
[TBL] [Abstract][Full Text] [Related]
18. Consequences of implementing a drug budget for office-based physicians in Germany.
Schöffski O
Pharmacoeconomics; 1996; 10 Suppl 2():37-47. PubMed ID: 10163434
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
Stafford RS; Furberg CD; Finkelstein SN; Cockburn IM; Alehegn T; Ma J
JAMA; 2004 Jan; 291(1):54-62. PubMed ID: 14709576
[TBL] [Abstract][Full Text] [Related]
20. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
